Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Immune Design Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Immune Design Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Immune Design Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Immune Design Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Immune Design Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Immune Design Corp, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Immune Design Raises US$32.5 Million In Series C Financing 12
Immune Design Raises US$34 Million In Series B Financing 14
Partnerships 16
Immune Design Enters into Agreement with Gritstone Oncology 16
Immune Design Enters into Clinical Trial Collaboration with Genentech 17
Immune Design Enters into Clinical Collaboration Agreement with Merck 18
Immune Design Enters into Co-Development Agreement with Sanofi Pasteur 19
Immune Design Enters Into Research Agreement With Cancer Research Institute And Ludwig Institute For Cancer Research 20
Licensing Agreements 22
Sanofi Enters into Licensing Agreement with Immune Design 22
Immune Design Enters into Licensing Agreement with UNC Chapel Hill 23
Immune Design Licensing Agreement with Oxford BioMedica 24
Immune Design And Medicago Enter Into Licensing Agreement To Develop Influenza Vaccines 25
Equity Offering 26
Immune Design Prices USD80 Million in Public Offering of Shares 26
Immune Design Prices Public Offering of Shares for USD30 Million 28
Immune design Plans to Raise up to USD50 Million in Public offering of Shares 30
Immune Design Completes Underwriters Partial Exercise of Over-Allotment of Public Offering of Shares 31
Immune Design Raises USD60 Million in IPO 33
Immune Design Corp – Key Competitors 35
Immune Design Corp – Key Employees 36
Immune Design Corp – Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Recent Developments 38
Financial Announcements 38
Aug 01, 2018: Immune Design reports second quarter 2018 financial results and provides corporate update 38
Mar 14, 2018: Immune Design Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update 40
Nov 01, 2017: Immune Design Reports Third Quarter 2017 Financial Results and Provides Corporate Update 42
Aug 02, 2017: Immune Design Reports Second Quarter 2017 Financial Results and Provides Corporate Update 44
May 17, 2017: Immune Design Reports First Quarter 2017 Financial Results and Provides Corporate Update 46
Mar 07, 2017: Immune Design Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update 48
Product News 50
09/25/2017: Immune Design Announces Upcoming Presentations at the SITC 32nd Annual Meeting 50
08/09/2018: Gritstone Oncology appoints experienced Financial Executive, Steve E. Krognes, to its Board of Directors 51
06/05/2017: Immune Design Updates Positive Data from Lead Cancer Immunotherapy Program CMB305 at ASCO Annual Meeting 52
06/01/2017: Immune responses from early study of novel sarcoma vaccine 54
05/17/2017: New Clinical and Biomarker Data Validate Immune Design’s CMB305 Program 56
Clinical Trials 58
May 24, 2018: Immune Design Announces Launch of Web Portal for SYNOVATE Phase 3 Study of CMB305 Immunotherapy in Synovial Sarcoma 58
Mar 12, 2018: Immune Design Reports Data Update for Lead Immunotherapy Program: Improvement in Survival for CMB305 Monotherapy in Sarcoma 59
Oct 16, 2017: Immune Design Announces Positive FDA Feedback on Phase 3 Clinical Trial Design for CMB305 in Synovial Sarcoma Patients 60
Sep 08, 2017: New Randomized Data From CMB305 + Checkpoint Inhibitor Study Demonstrate Greater Clinical Benefit and Immune Response 61
Aug 30, 2017: Immune Design Announces New CMB305 + Checkpoint Inhibitor Topline Data from an Upcoming Presentation at the ESMO 2017 Congress 63
Appendix 65
Methodology 65
About GlobalData 65
Contact Us 65
Disclaimer 65
Immune Design Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Immune Design Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Immune Design Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Immune Design Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Immune Design Corp, Deals By Therapy Area, 2012 to YTD 2018 9
Immune Design Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Immune Design Raises US$32.5 Million In Series C Financing 12
Immune Design Raises US$34 Million In Series B Financing 14
Immune Design Enters into Agreement with Gritstone Oncology 16
Immune Design Enters into Clinical Trial Collaboration with Genentech 17
Immune Design Enters into Clinical Collaboration Agreement with Merck 18
Immune Design Enters into Co-Development Agreement with Sanofi Pasteur 19
Immune Design Enters Into Research Agreement With Cancer Research Institute And Ludwig Institute For Cancer Research 20
Sanofi Enters into Licensing Agreement with Immune Design 22
Immune Design Enters into Licensing Agreement with UNC Chapel Hill 23
Immune Design Licensing Agreement with Oxford BioMedica 24
Immune Design And Medicago Enter Into Licensing Agreement To Develop Influenza Vaccines 25
Immune Design Prices USD80 Million in Public Offering of Shares 26
Immune Design Prices Public Offering of Shares for USD30 Million 28
Immune design Plans to Raise up to USD50 Million in Public offering of Shares 30
Immune Design Completes Underwriters Partial Exercise of Over-Allotment of Public Offering of Shares 31
Immune Design Raises USD60 Million in IPO 33
Immune Design Corp, Key Competitors 35
Immune Design Corp, Key Employees 36
Immune Design Corp, Other Locations 37
Immune Design Corp, Subsidiaries 37
List of Figures
Immune Design Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Immune Design Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Immune Design Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Immune Design Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Immune Design Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Immune Design Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Immune Design Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Immune Design Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9